Amikacin-loaded vascular prosthesis as an effective drug carrier

International Journal of Pharmaceutics

Volumn 339, Issue 1-2, 2007, Pages 39-46

  Ginalska, Grazyna ^a   Kowalczuk, Dorota ^a   Osińska, Monika ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Amikacin; Antibacterial capabilities; Drug release; Prosthetic biomaterial

Indexed keywords

AMIKACIN; BIODACYNA; BIOMATERIAL; DRUG CARRIER; GELATIN; POLYETHYLENE TEREPHTHALATE; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIOSTASIS; BLOOD VESSEL PROSTHESIS; CHEMICAL BOND; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; COVALENT BOND; DRUG RELEASE; ELUTION; ESCHERICHIA COLI; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEASUREMENT; MOLECULAR INTERACTION; NONHUMAN; PH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET SPECTROSCOPY;

AMIKACIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD VESSEL PROSTHESIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; HUMANS; MICROBIAL SENSITIVITY TESTS; POSTOPERATIVE COMPLICATIONS;

EID: 34250866750     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.02.016     Document Type: Article

References (34)

1. Anhalt J.P. Assays for antimicrobial agents in body fluids. In: Ballows A., Hausler W.J., Hermann K.L., Isenberg H.D., and Shadomy H.J. (Eds). Manual of Clinical Microbiology. fifth ed. (1991), American Society for Microbiology, Washington, DC 1192-1198
2. Avramovic J.R., and Fletcher J.P. Rifampicin impregnation of a protein-sealed Dacron graft: an infection-resistant prosthetic vascular graft. Surgical Research. Aust. N. Z. J. Surg. 61 (1991) 436-440
3. Belt H., Neut D., Schenke W., Horn J.R., der Mei H.C., and Busschner H.J. Staphylococcus aureus biofilm formation on different gentamicin-loaded poly(methyl methacrylate) bone cements. Biomaterials 22 (2001) 1607-1611
4. British Pharmacopoeia, I., 1999. Her Majestry's Stationary Office, London, pp. 695-697.
5. Chiesa R., Astore D., Piccolo G., Melissano G., Jannello A., Frigerio D., Agrifolio G., Bonalumi F., Corsi G., Constantini Brancadoro S., Novali C., Locati P., Odero A., Pirrelli S., Cugnasca M., Biglioli P., Sala A., Polvani G., Guarino A., Biasi G.M., Mingazzini P., Scalamogna M., Mantero S., Spina G., Prestipino F., and Sirchia G. Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homogara Group. Ann. Vasc. Surg. 5 (1998) 457-462
6. Earnshaw J.J. The current role of rifampicin-impregnated grafts: pragmatism versus science. Eur. J. Vasc. Endovasc. Surg. 20 (2000) 413-418
7. European Pharmacopoeia, 1997. Department for the Quality of Medicines, third ed., Strasbourg, pp. 104-111.
8. Frutos P., Torrado S., Perez-Lorenzo M.E., and Frutos G. A validated quantitative colorimetric assay for gentamicin. J. Pharm. Biomed. Anal. 21 (2000) 1149-1159
9. Gahtan V., Esses G.E., Bandyk D.F., Nelson R.T., Dupont E., and Mills J.L. Antistaphylococcal activity of rifampin-bonded gelatin impregnated Dacron prosthesis. J. Surg. Res. 58 (1995) 105-110
10. Galdbart J.O., Branger C., Andreassian B., Lambert-Zechovsky N., and Kitzis M. Elution of six antibiotics bonded to polyethylene vascular grafts sealed with three proteins. J. Surg. Res. 66 (1996) 174-178
11. Ginalska G., Kowalczuk D., and Osińska M. A chemical metod of gentamicin bonding to gelatine-sealed prosthetic vascular grafts. Int. J. Pharm. 288 (2005) 131-140
12. Ginalska G., Osińska M., Uryniak A., Urbanik-Sypniewska T., Belcarz A., Rzeski W., and Wolski A. Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene terephthalate vascular prostheses. Eur. J. Vasc. Endovasc. Surg. 29 (2005) 419-424
13. Ginalska, G., Uryniak, A., Łobarzewski, J., Osińska, M., 2004. A method of antibiotics immobilization. Polish Patent Pending no. P-358934, Polish Patent Office Bulletin, 18, 801, p. 128.
14. Gringauz A. Introduction to Medicinal Chemistry (1997), Wiley-VCH Inc., New York
15. Haverich A., Hirt S., Karck M., Sialari F., and Wahling H. Prevention of graft infection by bonding gentamicin to Dacron prostheses. J. Vasc. Surg. 15 (1992) 187-193
16. Hermanson G.T., Krishna Mallia A., and Smith P.K. Immobilized Affinity Ligand Techniques (1992), Academic Press, INC
17. Hernández-Richter T., Schardey H.M., Wittman F., Mayr S., Schmitt-Sody M., Blasenbreu S., Heiss M.M., Gabka C., and Angele M.K. Rifampin and triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material. Eur. J. Vasc. Endovasc. Surg. 26 (2003) 550-557
18. Huh J., Chen J.G., Furman G.M., Malki Ch., King B., Kafie F., and Wilson S.E. Local treatment of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin. J. Surg. Res. 74 (1998) 54-58
19. Kikta M.J., Goodman L.J., and Bishara R.A. Mortabilioty and limb loss with infected infrainguinal bypass grafts. J. Vas. Surg. 5 (1987) 566-571
20. Lovering A.M., and MacGowan A.P. A comparative study of the rifampicin binding and elution characteristics for collagen- and albumin-sealed vascular grafts. Eur. J. Vasc. Endovasc. Surg. 17 (1996) 347-350
21. Lo{combining double acute accent}wdin E., Odenholt I., and Cars O. In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 42 (1998) 2739-2744
22. Moore W.S., and Cole C.W. Infection in prosthetic vascular grafts. In: Moore W.S. (Ed). Vascular Surgery: A Comprehensive Review (1991), Saunders, Philadelphia, PA 598-609
23. Millesime L., Dulieu J., and Chaufer B. Protein retention with modified and unmodified inorganic ultrafiltration membranes: model of ionic strength controlled retention. J. Membr. Sci. 108 (1995) 143-159
24. Nevelesten A., Lacroix H., and Suy R. Autegonous reconstruction with lower extremity deep veins: an alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J. Vasc. Surg. 2 (1995) 129-134
25. Nevelesten A., Lacroix H., and Suy R. Infrarenal aortic graft infection: in situ aortoiliofemoral reconstruction with the lower extremity deep veins. Eur. J. Vasc. Endovasc. Surg. Suppl. A 14 (1997) 88-92
26. Novali C. Vascular homografts: strategies and operative techniques. Ann. Ital. Chir. 2 (2001) 141-147
27. Omri A., and Ravaoarinoro M. Preparation, properties and the effects of amikacin, netilmicin and tobramycin in free and liposomal formulations on Gram-negative and Gram-positive bacteria. J. Antimicrob. Agents 7 (1996) 9-14
28. Pipinos I.I., Carr J.A., Haithcock B.E., Anagnostopoulos P.V., Dossa C.D., and Reddy D.J. Secondary aortoenteric fistula. Ann. Vasc. Surg. 6 (2000) 688-696
29. Ristuccia A.M., and Cunha B.A. An overview of amikacin. Ther. Drug Monit. 7 (1985) 12-25
30. Sánchez-Martinez M.L., Aguilar-Caballos M.P., and Gómez-Hens A. Selective kinetic determination of amikacin in serum using long-wavelength fluorimetry. J. Pharm. Biomed. Anal. 34 (2004) 1021-1027
31. Stigter M., Bezemer J., de Groot K., and Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J. Control. Rel. 99 (2004) 127-137
32. Strachan C.J.L., Newston S.W.B., and Ashton T.R. The clinical use of an antibiotic-bonded graft. Eur. J. Vasc. Surg. 5 (1991) 627-632
33. Szilagyi D.E., Smith R.F., Elliott J.P., and Vrandecic M.P. Infection in arterial reconstruction with synthetic grafts. Ann. Surg. 3 (1972) 321-333
34. Vicaretti M., Hawthorne W.J., Ao P.Y., and Fletcher J.P. An increased concentration of rifampicin bonded to gelatin sealed Dacron reduces the incidence of subsequent graft infection following a staphylococcal challenge. Cardiovasc. Surg. 6 (1998) 268-273